Company intelligence / Profile preview

Bruno Vision Care

Boca Raton, Florida, United Statesthevisioncouncil.org ↗

Ownership: Private
Development stage: Commercial

Overview

Deseyne® daily disposable contact lenses have received FDA approval based on their novel material and controlled-release technology. The product delivers sustained ocular hydration and comfort via embedded bioactives. Clinical data supporting safety and efficacy were sufficient for Class II medical device clearance. Full clinical results are not detailed in public sources but regulatory approval indicates successful demonstration of intended performance.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Consumable Medical Devices

Drug pipeline

1 asset

Deseyne

Commercial

Indications: Vision impairment, Dry eye disease

Partnerships

Safilens S.r.l.

Beyond the preview

Go deeper on Bruno Vision Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bruno Vision Care.

Explore the full profile